Compare EL & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EL | WAT |
|---|---|---|
| Founded | 1946 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9B | 33.5B |
| IPO Year | 2007 | 1996 |
| Metric | EL | WAT |
|---|---|---|
| Price | $94.05 | $422.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 17 |
| Target Price | $97.60 | ★ $379.19 |
| AVG Volume (30 Days) | ★ 3.0M | 584.3K |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.85% | N/A |
| EPS Growth | ★ 115.87 | 0.47 |
| EPS | ★ 0.50 | N/A |
| Revenue | ★ $15,049,000,000.00 | N/A |
| Revenue This Year | $7.51 | $104.66 |
| Revenue Next Year | $4.08 | $10.40 |
| P/E Ratio | $189.24 | ★ N/A |
| Revenue Growth | ★ 5.05 | N/A |
| 52 Week Low | $66.22 | $282.77 |
| 52 Week High | $121.64 | $431.78 |
| Indicator | EL | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 45.70 | 59.39 |
| Support Level | $90.81 | $372.33 |
| Resistance Level | $109.46 | $426.22 |
| Average True Range (ATR) | 2.85 | 10.58 |
| MACD | -1.37 | 0.68 |
| Stochastic Oscillator | 9.50 | 74.80 |
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%). Top-selling brands include Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.